CLASS II ONGOING Drug recall · Reported 7 Jun 2023 · FDA Enforcement Report
Lactulose Solution, USP (Oral) recalled by Akorn
Akorn is recalling Lactulose Solution, USP (Oral), distributed nationwide in the US. The recall was initiated on 26 Apr 2023 and the FDA has classified it as Class II.
Check your package
Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.
Recall details
- Recall number
- D-0814-2023
- FDA event ID
- 91788
- Recalling firm
- Akorn, Gurnee, IL
- Classification
- Class II
- Status
- Ongoing
- Recall initiated
- 26 Apr 2023
- FDA classified
- 1 Jun 2023
- Reported
- 7 Jun 2023
- Type
- Voluntary: Firm initiated
- Customers notified by
- Letter
- Reason category
- Potency & Assay
Timeline
| 26 Apr 2023 | Recall initiated by company | |
| 1 Jun 2023 | Classified by FDA | +36 days |
| 7 Jun 2023 | Published in enforcement report | +6 days |
Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.
Reason for recall
CGMP Deviations: Firm went out of business and could no longer continue stability studies.
Potency and specification recalls happen when a batch tests outside its approved limits for strength, purity or dissolution, which can mean the dose delivered is higher or lower than labelled.
Product as listed by the FDA
Lactulose Solution, USP (Oral), 10g/15 mL, packaged in a) 15mL bottles, b) 30 mL bottles, c) 473 mL bottles, and d) 946 mL bottles, Rx Only, Distributed by: Akorn, Inc., Gurnee, IL 60031. ALL NDCs
Where it was distributed
Nationwide in the USA and Puerto Rico
Questions about this recall
Is Lactulose Solution, USP (Oral) recalled?
Yes. Akorn recalled Lactulose Solution, USP (Oral) on 26 Apr 2023. The recall is Class II and its status is Ongoing. Recall number D-0814-2023.
Why was it recalled?
CGMP Deviations: Firm went out of business and could no longer continue stability studies.
Which lots are affected?
All Lots
Where was it sold?
Nationwide in the USA and Puerto Rico
What should I do if I have it?
Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.
What does Class II mean?
Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.
Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.
More recalls from Akorn
All 192| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Timolol Maleate Ophthalmic Solution recalled by Akorn | Akorn | Potency & Assay | Nationwide |
| Drug | CLASS II | Calcipotriene Topical Solution, 005% (Scalp Solution) recalled by Akorn | Akorn | Potency & Assay | Nationwide |
| Drug | CLASS II | Midazolam Injection, USP, 50 mg/ (5mg/mL) recalled by Akorn | Akorn | Potency & Assay | Nationwide |
| Drug | CLASS II | Lidocaine Ointment USP, 5%, 1 tubes recalled by Akorn | Akorn | Potency & Assay | Nationwide |
| Drug | CLASS II | Midazolam Injection, USP 2mg recalled by Akorn | Akorn | Potency & Assay | Nationwide |
Other Lactulose recalls
All 9| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Lactulose Solution, USP (For oral or rectal administration) recalled | Akorn | Potency & Assay | Nationwide |
| Drug | CLASS II | Lactulose Solution, USP, For Oral Administration recalled | Torrent Pharma | Sterility | Nationwide |
| Drug | CLASS II | Lactulose Solution, USP, For Oral or Rectal Administration recalled | Torrent Pharma | Sterility | Nationwide |
| Drug | CLASS II | Lactulose Solution, USP, dose cups delivers packaged dose cups recalled | VistaPharm | Mold | 7 states |
| Drug | CLASS II | Lactulose Solution, USP, dose cups delivers recalled by VistaPharm | VistaPharm | Mold | 7 states |